GLP-1 Patent Expiries Bring Affordable Access and Counterfeit Risks

GLP-1 medicines are special medicines that help people who are very overweight, and they also help with diabetes and heart health.

More than one billion people around the world struggle with obesity, so these medicines are very important.

These medicines have become very popular, and governments are spending a lot more money on them.

When a company's patent ends, other companies are allowed to make the same medicine, which makes it cheaper.

That already happened in Brazil, where five new versions of one medicine were approved.

India could become a big maker of these medicines for the whole world.

But there is a problem: fake versions of these medicines are appearing in some markets.

The FDA has warned people about these fake medicines because they can be dangerous.

That is why doctors, companies, and regulators all need to work together to keep patients safe.